網膜芽細胞腫の遺伝子

The Rb gene was the first-ever tumor suppressor gene discovered. It encodes retinoblastoma protein that regulates cell cycle progression in healthy individuals. Tumor suppressor genes slow down cell division, repair DNA mistakes, or program cells for apoptosis when damage is irreparable. Loss of Rb function allows cells to divide uncontrollably, leading to cancer development.

In hereditary retinoblastoma, a child inherits one functional and one mutated Rb gene. Every somatic cell has only one normal copy, producing enough Rb protein to maintain normal cell cycle initially. However, if any cell loses the second functional copy through mutation, it stops producing Rb protein entirely and becomes cancerous. This two-hit mechanism explains why hereditary carriers develop tumors.

Hereditary retinoblastoma occurs when a child inherits one defective Rb gene copy, predisposing them to tumors in both eyes. Sporadic retinoblastoma develops when a single cell undergoes two independent somatic mutations and loses both functional Rb gene copies without inheritance. Hereditary cases comprise 25-35% of retinoblastoma cases, while sporadic cases comprise 65-75%, typically affecting only one eye.

Hereditary retinoblastoma patients inherit one mutated Rb gene in all somatic cells. Since retinal cells in both eyes carry this mutation, the probability that each eye's cells will independently lose the second functional Rb gene copy is high. This independent loss of function in cells from both eyes leads to tumor development in both eyes rather than just one.

In individuals who inherit one functional Rb gene copy, the amount of Rb protein produced from that single copy is sufficient to maintain normal cell cycle regulation and prevent cancer. However, this protection is incomplete—if the remaining functional copy is lost in any somatic cell, that cell loses all Rb protein production and becomes cancerous, demonstrating the critical threshold for tumor suppression.

Retinoblastoma is one of the most common intraocular malignant tumors in children, with an incidence rate of approximately 1 in 15,000 to 1 in 18,000 births. The disease occurs in both hereditary and nonhereditary forms, with the nonhereditary form being more prevalent overall, accounting for the majority of cases in pediatric populations.

Yes, in rare cases, an individual with two functional Rb gene copies can develop sporadic retinoblastoma when both copies are lost or inactivated by two independent somatic mutations occurring in a single retinal cell lineage over time. These acquired mutations accumulate without inheritance, resulting in loss of tumor suppressor function and cancer development in that cell's descendants.